BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36208028)

  • 1. Phenotype of BTK-lacking myeloid cells during prolonged COVID-19 and upon convalescent plasma.
    Gomes AMC; Farias GB; Trombetta AC; Godinho-Santos A; Parreira I; Gonçalves HD; Simões ML; Aguiar P; Deveza MM; Inácio J; Sousa AE; da Silva SL
    Eur J Haematol; 2023 Feb; 110(2):209-212. PubMed ID: 36208028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency.
    Ponsford MJ; Shillitoe BMJ; Humphreys IR; Gennery AR; Jolles S
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):525-534. PubMed ID: 34596095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.
    Marron TU; Martinez-Gallo M; Yu JE; Cunningham-Rundles C
    J Allergy Clin Immunol; 2012 Jan; 129(1):184-90.e1-4. PubMed ID: 22088613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B Cells and COVID-19: Lessons From Patients With Agammaglobulinemia and the Study of Functional B-Cell Polymorphisms.
    Speletas M; Raftopoulou S; Farmaki E; Gatselis N; Germanidis G; Mouchtouri VA; Hatzianastasiou S; Georgiadou S; Tsinti G; Tsachouridou O; Tseroni M; Metallidis S; Dalekos G; Eibel H; Hadjichristodoulou C
    J Investig Allergol Clin Immunol; 2021 Feb; 32(1):53-55. PubMed ID: 34159904
    [No Abstract]   [Full Text] [Related]  

  • 5. Case Report: A Case of X-Linked Agammaglobulinemia With High Serum IgE Levels and Allergic Rhinitis.
    Cinicola B; Uva A; Leonardi L; Moratto D; Giliani S; Carsetti R; Ferrari S; Zicari AM; Duse M
    Front Immunol; 2020; 11():582376. PubMed ID: 33224144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
    Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
    Front Immunol; 2020; 11():2001. PubMed ID: 33013854
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency.
    Mirsafian H; Ripen AM; Leong WM; Chear CT; Bin Mohamad S; Merican AF
    Sci Rep; 2017 Jul; 7(1):6836. PubMed ID: 28754963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
    Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of four novel mutations in BTK from six Chinese families with X-linked agammaglobulinemia.
    Zhou Q; Teng Y; Pan J; Shi Q; Liu Y; Zhang F; Liang D; Li Z; Wu L
    Clin Chim Acta; 2022 Jun; 531():48-55. PubMed ID: 35245483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.
    Gao S; Hu S; Duan H; Wang L; Kong X
    BMC Med Genet; 2020 Jun; 21(1):131. PubMed ID: 32552675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
    Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
    J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic profiles of patients with X-linked agammaglobulinemia from southeast Turkey: Novel mutations in BTK gene.
    Doğruel D; Serbes M; Şaşihüseyinoğlu AŞ; Yılmaz M; Altıntaş DU; Bişgin A
    Allergol Immunopathol (Madr); 2019; 47(1):24-31. PubMed ID: 30072168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
    Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
    Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model.
    Bestas B; Moreno PM; Blomberg KE; Mohammad DK; Saleh AF; Sutlu T; Nordin JZ; Guterstam P; Gustafsson MO; Kharazi S; Piątosa B; Roberts TC; Behlke MA; Wood MJ; Gait MJ; Lundin KE; El Andaloussi S; Månsson R; Berglöf A; Wengel J; Smith CI
    J Clin Invest; 2014 Sep; 124(9):4067-81. PubMed ID: 25105368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia.
    Gray DH; Villegas I; Long J; Santos J; Keir A; Abele A; Kuo CY; Kohn DB
    CRISPR J; 2021 Apr; 4(2):191-206. PubMed ID: 33876953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel
    Shaka Z; Mojtabavi H; Rayzan E; Zoghi S; Shahkarami S; Raul JH; Sedighi I; Boztug K; Rezaei N
    Allergol Immunopathol (Madr); 2021; 49(2):80-83. PubMed ID: 33641298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement.
    Cavaliere FM; Prezzo A; Bilotta C; Iacobini M; Quinti I
    PLoS One; 2017; 12(4):e0175961. PubMed ID: 28422989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia.
    Toker O; Broides A; Lev A; Simon AJ; Megged O; Shamriz O; Tal Y; Somech R; Lee YN; Nahum A
    Immunol Res; 2022 Apr; 70(2):216-223. PubMed ID: 35001352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
    Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
    Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia.
    Kraft MT; Pyle R; Dong X; Hagan JB; Varga E; van Hee M; Boyce TG; Pozos TC; Yilmaz-Demirdag Y; Bahna SL; Abraham RS
    Clin Immunol; 2021 Aug; 229():108788. PubMed ID: 34182127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.